| 发明名称 |
THERAPEUTIC AGENT FOR CANCER WHICH COMPRISES COMBINATION OF IL-18 AND MOLECULE-TARGETING ANTIBODY |
| 摘要 |
A therapeutic agent for cancer according to the present invention contains, as active ingredients, IL-18 and at least one antibody selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody and an anti-CD52 antibody. |
| 申请公布号 |
WO2016021720(A1) |
申请公布日期 |
2016.02.11 |
| 申请号 |
WO2015JP72505 |
申请日期 |
2015.08.07 |
| 申请人 |
HYOGO COLLEGE OF MEDICINE |
发明人 |
OKAMURA, HARUKI;YAMANISHI, KYOSUKE;LI, WEN |
| 分类号 |
A61K38/00;A61K39/395;A61P35/00;A61P35/02;A61P43/00 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
